Coric Vlad

CIK 00017043176 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001704317

Recent Transactions

50 trades

Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2026-06-05+4,545→ 15,343 total
Award
Biohaven Ltd.$BHVN
Stock Options (Right to buy)
2026-02-27+550,000→ 550,000 total
Purchase
Veradermics, Inc$MANE
Common Stock
2026-02-05$17.00/sh+58,823→ 319,398 total
Conversion
Veradermics, Inc$MANE
Series C Convertible Preferred Stock
2026-02-05−78,075→ 0 total
Conversion
Veradermics, Inc$MANE
Series A Convertible Preferred Stock
2026-02-05−33,706→ 0 total
Conversion
Veradermics, Inc$MANE
Series B Convertible Preferred Stock
2026-02-05−148,794→ 0 total
Conversion
Veradermics, Inc$MANE
Series B Convertible Preferred Stock
2026-02-05−148,794→ 0 total
Conversion
Veradermics, Inc$MANE
Common Stock
2026-02-05+33,706→ 33,706 total
Conversion
Veradermics, Inc$MANE
Common Stock
2026-02-05+78,075→ 260,575 total
Conversion
Veradermics, Inc$MANE
Common Stock
2026-02-05+148,794→ 182,500 total
Conversion
Veradermics, Inc$MANE
Series A Convertible Preferred Stock
2026-02-05−33,706→ 0 total
Conversion
Veradermics, Inc$MANE
Common Stock
2026-02-05+148,794→ 182,500 total
Conversion
Veradermics, Inc$MANE
Series C Convertible Preferred Stock
2026-02-05−78,075→ 0 total
Conversion
Veradermics, Inc$MANE
Common Stock
2026-02-05+33,706→ 33,706 total
Conversion
Veradermics, Inc$MANE
Common Stock
2026-02-05+78,075→ 260,575 total
Purchase
Veradermics, Inc$MANE
Common Stock
2026-02-05$17.00/sh+58,823→ 319,398 total
Conversion
Veradermics, Inc$MANE
Series C Convertible Preferred Stock
2026-02-05−117,112→ 0 total
Conversion
Veradermics, Inc$MANE
Common Stock
2026-02-05+117,112→ 129,939 total
Award
Veradermics, Inc$MANE
Stock Option (Right to Buy)
2026-02-03+51,525→ 51,525 total
Tax Payment
Biohaven Ltd.$BHVN
Common Shares
2026-01-05$9.93/sh−7,430→ 1,803,968 total
Exercise/Conversion
Biohaven Ltd.$BHVN
Common Shares
2026-01-05+14,250→ 1,811,398 total
Exercise/Conversion
Biohaven Ltd.$BHVN
Restricted Share Unit Award
2026-01-05−14,250→ 28,500 total
Purchase
Biohaven Ltd.$BHVN
Common Shares
2025-11-13$7.50/sh+333,333→ 740,546 total
Purchase
Biohaven Ltd.$BHVN
Common Shares
2025-11-13$7.50/sh+333,333→ 1,195,275 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-05-13+7,614→ 10,798 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-04-21+3,184→ 3,184 total
Disposition to Issuer
Revance Therapeutics, Inc.
Common Stock
2025-02-06−15,000→ 0 total
Disposition from Tender
Revance Therapeutics, Inc.
Common Stock
2025-02-04$3.65/sh−5,784→ 15,000 total
Award
Biohaven Ltd.$BHVN
Stock Options (Right to buy)
2025-01-05+343,000→ 343,000 total
Award
Biohaven Ltd.$BHVN
Restricted Share Unit Award
2025-01-05+57,000→ 57,000 total
Exercise/Conversion
Biohaven Ltd.$BHVN
Restricted Share Unit Award
2025-01-05−14,250→ 42,750 total
Tax Payment
Biohaven Ltd.$BHVN
Common Shares
2025-01-05$38.64/sh−6,805→ 1,796,604 total
Exercise/Conversion
Biohaven Ltd.$BHVN
Common Shares
2025-01-05+14,250→ 1,803,409 total
Purchase
Biohaven Ltd.$BHVN
Common Shares
2024-10-02$47.50/sh+21,052→ 861,942 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2024-05-01+23,458→ 23,458 total
Award
Revance Therapeutics, Inc.
Common Stock
2024-05-01+15,000→ 20,784 total
Purchase
Biohaven Ltd.$BHVN
Common Shares
2024-04-22$41.00/sh+121,951→ 1,788,417 total
Award
Biohaven Ltd.$BHVN
Common Shares
2024-04-05+231→ 407,213 total
Award
Biohaven Ltd.$BHVN
Common Shares
2024-04-05+231→ 840,890 total
Award
Biohaven Ltd.$BHVN
Common Shares
2024-04-05+232→ 1,666,466 total
Award
Biohaven Ltd.$BHVN
Common Shares
2024-03-08+2,162→ 1,666,234 total
Award
Biohaven Ltd.$BHVN
Common Shares
2024-03-08+2,155→ 840,659 total
Award
Biohaven Ltd.$BHVN
Common Shares
2024-03-08+2,155→ 406,982 total
Award
Biohaven Ltd.$BHVN
Common Shares
2024-01-08+5,384→ 404,827 total
Award
Biohaven Ltd.$BHVN
Common Shares
2024-01-08+5,384→ 838,504 total
Award
Biohaven Ltd.$BHVN
Common Shares
2024-01-08+5,400→ 1,662,431 total
Award
Biohaven Ltd.$BHVN
Stock Options (Right to buy)
2024-01-02+275,000→ 275,000 total
Award
Biohaven Ltd.$BHVN
Stock Options (Right to buy)
2023-11-02+225,000→ 225,000 total
Purchase
Biohaven Ltd.$BHVN
Common Shares
2023-10-05$22.00/sh+113,637→ 1,657,031 total
Purchase
Biohaven Ltd.$BHVN
Common Share
2023-10-05$22.00/sh+340,908→ 833,120 total

Companies

Recent Filings

Address

C/O ROYALTY PHARMA PLC 110 E. 59TH STREET

NEW YORK, NY, 10022

View on SEC.gov